Fox Chase Cancer Center News

PHILADELPHIA (October 2, 2023) — Radiodynamic therapy at specific energy levels help effectively reduce tumor size in combination with the amino acid 5-aminolevulinic acid, according to findings presented by a Fox Chase Cancer Center researcher recently at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Diego.

PHILADELPHIA (October 2, 2023) — The presence of BRCA1 and BRCA2 mutations in breast cancer patients did not predict improved survival for patients who received radiation therapy, according to findings presented by Fox Chase Cancer Center researchers recently at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Diego.

PHILADELPHIA (September 19, 2023) — Melissa Culligan, RN, MS, PhD candidate, director of Thoracic Surgery Research at Temple Health, was recently honored with the International Association for the Study of Lung Cancer’s (IASLC) Lectureship Award for Nurses and Allied Health Professionals.

PHILADELPHIA (September 13, 2023) — Fox Chase Cancer Center is pleased to announce the hiring of Parth A. Desai, MD, as an assistant professor in the Department of Hematology/Oncology. His clinical practice will be based at the department’s rapidly expanding section at Temple University Hospital, where his clinical practice will focus on head and neck cancer, thoracic malignancies, and translational clinical trials.

PHILADELPHIA (September 12, 2023)—Sara Small, MD, PhD, an Assistant Professor in the Department of Bone Marrow Transplant and Cellular Therapies at Fox Chase Cancer Center, has received a Research Training Award for Fellows from the American Society of Hematology (ASH).

PHILADELPHIA (September 12, 2023) — Fox Chase Cancer Center is pleased to announce the hiring of Sara Small, MD, PhD, as an assistant professor in the Department of Bone Marrow Transplant and Cellular Therapies.

PHILADELPHIA (September 7, 2023) — Researchers at Fox Chase Cancer Center have published the results of a phase 1 study that showed that the cytokine interferon-gamma may help reduce serious immune-related adverse events that can occur with the use of the immune checkpoint inhibitor drug nivolumab.

PHILADELPHIA (September 6, 2023) — Anna Liza Rodriguez, MSN, MHA, RN, OCN, NEA-BC, Chief Nursing Officer at Fox Chase Cancer Center, is a finalist in the Nursing Administration – Executive/CNO category for the 2023 Nightingale Awards of Pennsylvania, which recognize nursing excellence in the state. The award that Rodriguez is a finalist for recognizes an individual who demonstrates visionary leadership, implements innovations, and promotes effective financial stewardship of operational human resources.